drugset / Trial / NCT04474990

Single-Patient Expanded Access Protocol for Tradipitant In A Single Patient With Gastroparesis

NCT04474990 ↗

Expanded access Available Vanda Pharmaceuticals

Summary

Primary Objective: To treat a single patient with gastroparesis who has requested expanded access with tradipitant

Timeline

Start
—
Primary completion
—
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject Tradipitant Small molecule 85 mg —

Indications